Robert W. Duggan - 12 May 2021 Form 4 Insider Report for Summit Therapeutics Inc. (SMMT)

Role
Chief Executive Officer, Director, 10%+ Owner
Signature
/s/ Michael Paul Donaldson, Attorney-in-Fact
Issuer symbol
SMMT
Transactions as of
12 May 2021
Net transactions value
+$59,557,426
Form type
4
Filing time
14 May 2021, 16:39:10 UTC
Next filing
21 May 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SMMT Common Stock Purchase $59,557,426 +11,365,921 +20% $5.24 67,662,454 12 May 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the number of shares of Common Stock that the Reporting Person purchased in the Issuer's rights offering.